These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22424018)

  • 1. Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).
    Reynolds HR; Forman SA; Tamis-Holland JE; Steg PG; Mark DB; Pearte CA; Carvalho AC; Sopko G; Liu L; Lamas GA; Kruk M; Loboz-Grudzien K; Ruzyllo W; Hochman JS
    Am Heart J; 2012 Mar; 163(3):462-9. PubMed ID: 22424018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.
    Hochman JS; Reynolds HR; Dzavík V; Buller CE; Ruzyllo W; Sadowski ZP; Maggioni AP; Carvalho AC; Rankin JM; White HD; Goldberg S; Forman SA; Mark DB; Lamas GA;
    Circulation; 2011 Nov; 124(21):2320-8. PubMed ID: 22025606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.
    Kruk M; Kadziela J; Reynolds HR; Forman SA; Sadowski Z; Barton BA; Mark DB; Maggioni AP; Leor J; Webb JG; Kapeliovich M; Marin-Neto JA; White HD; Lamas GA; Hochman JS
    JACC Cardiovasc Interv; 2008 Oct; 1(5):511-20. PubMed ID: 19194534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary intervention for persistent occlusion after myocardial infarction.
    Hochman JS; Lamas GA; Buller CE; Dzavik V; Reynolds HR; Abramsky SJ; Forman S; Ruzyllo W; Maggioni AP; White H; Sadowski Z; Carvalho AC; Rankin JM; Renkin JP; Steg PG; Mascette AM; Sopko G; Pfisterer ME; Leor J; Fridrich V; Mark DB; Knatterud GL;
    N Engl J Med; 2006 Dec; 355(23):2395-407. PubMed ID: 17105759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT).
    Malek LA; Reynolds HR; Forman SA; Vozzi C; Mancini GB; French JK; Dziarmaga M; Renkin JP; Kochman J; Lamas GA; Hochman JS
    Am Heart J; 2009 Apr; 157(4):724-32. PubMed ID: 19332202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).
    Jhaveri RR; Reynolds HR; Katz SD; Jeger R; Zinka E; Forman SA; Lamas GA; Hochman JS
    J Card Fail; 2012 Nov; 18(11):813-21. PubMed ID: 23141853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
    White HD; Reynolds HR; Carvalho AC; Pearte CA; Liu L; Martin CE; Knatterud GL; Džavík V; Kruk M; Steg PG; Cantor WJ; Menon V; Lamas GA; Hochman JS
    Am Heart J; 2012 Apr; 163(4):563-71. PubMed ID: 22520521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]).
    Kruk M; Buller CE; Tcheng JE; Dzavík V; Menon V; Mancini GB; Forman SA; Kurray P; Busz-Papiez B; Lamas GA; Hochman JS
    Am J Cardiol; 2010 Jan; 105(1):10-6. PubMed ID: 20102883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial.
    Cantor WJ; Baptista SB; Srinivas VS; Pearte CA; Menon V; Sadowski Z; Ross JR; Meciar P; Nikolsky E; Forman SA; Lamas GA; Hochman JS
    Am Heart J; 2009 Apr; 157(4):666-72. PubMed ID: 19332193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.
    Menon V; Pearte CA; Buller CE; Steg PG; Forman SA; White HD; Marino PN; Katritsis DG; Caramori P; Lasevitch R; Loboz-Grudzien K; Zurakowski A; Lamas GA; Hochman JS
    Eur Heart J; 2009 Jan; 30(2):183-91. PubMed ID: 19028780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial).
    Skolnick AH; Reynolds HR; White HD; Menon V; Carvalho AC; Maggioni AP; Pearte CA; Gruberg L; Azevedo RE; Schroeder E; Forman SA; Lamas GA; Hochman JS; Džavík V
    Am J Cardiol; 2012 Mar; 109(5):614-9. PubMed ID: 22172242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).
    Lang IM; Forman SA; Maggioni AP; Ruzyllo W; Renkin J; Vozzi C; Steg PG; Hernandez-Garcia JM; Zmudka K; Jimenez-Navarro M; Sopko G; Lamas GA; Hochman JS
    EuroIntervention; 2009 Nov; 5(5):610-8. PubMed ID: 20142183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
    Buller CE; Rankin JM; Carere RG; Buszman PE; Pfisterer ME; Dzavik V; Thomas B; Forman S; Ruzyllo W; Mancini GB; Michalis LK; Abreu PF; Lamas GA; Hochman JS
    Am Heart J; 2009 Sep; 158(3):408-15. PubMed ID: 19699864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial.
    Steg PG; Kerner A; Mancini GB; Reynolds HR; Carvalho AC; Fridrich V; White HD; Forman SA; Lamas GA; Hochman JS; Buller CE;
    Circulation; 2010 Jun; 121(25):2724-30. PubMed ID: 20547926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).
    Menon V; Ruzyllo W; Carvalho AC; Almeida de Sousa JM; Forman SA; Jaworska K; Lamas GA; Roik M; Thuaire C; Turgeman Y; Hochman JS
    Am J Cardiol; 2013 Apr; 111(7):930-5. PubMed ID: 23351464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.
    Udelson JE; Pearte CA; Kimmelstiel CD; Kruk M; Kufera JA; Forman SA; Teresinska A; Bychowiec B; Marin-Neto JA; Höchtl T; Cohen EA; Caramori P; Busz-Papiez B; Adlbrecht C; Sadowski ZP; Ruzyllo W; Kinan DJ; Lamas GA; Hochman JS
    Am Heart J; 2011 Mar; 161(3):611-21. PubMed ID: 21392619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.
    Adlbrecht C; Huber K; Reynolds HR; Carvalho AC; Džavík V; Steg PG; Liu L; Marino P; Pearte CA; Rankin JM; White HD; Lamas GA; Hochman JS
    Int J Cardiol; 2014 Jun; 174(1):90-5. PubMed ID: 24726166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).
    Rashba EJ; Lamas GA; Couderc JP; Hollist SM; Dzavik V; Ruzyllo W; Fridrich V; Buller CE; Forman SA; Kufera JA; Carvalho AC; Hochman JS;
    Circulation; 2009 Feb; 119(6):779-87. PubMed ID: 19188505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment.
    Hastings RS; Hochman JS; Dzavik V; Lamas GA; Forman SA; Schiele F; Michalis LK; Nikas D; Jaroch J; Reynolds HR
    Am J Cardiol; 2012 Oct; 110(7):954-60. PubMed ID: 22728005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.